Trial intelligence / Profile preview

Misodel vs Oral Misoprostol for Labor Induction

NCT02918110Phase 4Unknown

Sponsor
Karolinska Institutet
Start
Sep 2016
Primary completion
Sep 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of Misopess in labor induction, sponsored by Karolinska Institutet. Primary endpoint: Cesarean section rate at 1 year. Status: unknown.

02

Drugs

Misopess
03

Conditions

labor induction

Beyond the preview

Go deeper on NCT02918110.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02918110.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call